Tag: Pharmaceutical Industry

Sofinnova Partners sets up a new fund to invest in biopharmaceutical sector

Sofinnova Partners, a leading European venture capital firm specialized in Life Sciences, announced the launch of Sofinnova Crossover I with €275 million, above the original first close target of €250 million.

GlobalData forecasts an increasingly widespread use of monoclonal antibodies

monoclonal antibodies
Ever since the first commercial mAbs was approved in 1986 for human therapeutic purposes, mAbs have been increasingly used in several areas of healthcare.

Amgen considers Turkey as a regional biopharmaceutical hub

The increase experienced in the domestic industry with the incentives issued by the government in a program with the pharmaceutical industry among primary strategic products, drew the attention of top pharma players to Turkey.

Ukrainian pharma market is suffering from monopolies and oligopolies

Ukrainian health sector legislative base is still weak, and health reforms only just starting to kick in, experts say better regulation and a systematic approach to reform are still needed to nurse the sector back to health.

Russia offers to open a “green channel” for Japanese pharmaceutical companies

Russia proposed to open so-called “green channel” for Japanese pharmaceutical and medical device companies. This was announced by the Russian Deputy Prime Minister Olga Golodets.

Milan hosted a convention of the Russian-Italian subgroup for pharma industry

A delegation of the Russian Ministry of Industry and Trade lead by the Head of the Department of Pharmaceutical and Medical Industry Development – arrived in Italy with a mission to support cooperation between the countries.

New technologies require adjustments to the development of pharma industry

The Russian Minister of Industry and Trade, said that he expects drug manufacturing to grow in 2018. The innovative approaches require the adjustments to the development strategy of pharmaceutical industry.

GlobalData expects that Merck will set to lead licensing deals in 2018

Companies’ financial success is often down to the strategic deals they are able to make with other pharmaceutical companies to enable them to develop the next leading drug in the market, observes GlobalData

70 import-substituting Russian medicines were launched onto the market

The production of high-quality, domestically manufactured drugs in the key segments allows to make significant savings of budgetary funds and reduces the dependence of Russian health care system on the imports of medicines

Ukrainian pharma manufacturers are concerned by National medicines list

Participants in the pharmaceutical market are concerned about a lack of transparency in the formation of the National List of Essential Medicines, as well as the definition of nosologies that it covers

Medical software company BaseCase has been acquired by Certara

Certara, a leading drug development consultancy, announced that it has acquired BaseCase Management GmbH, a data visualization software as a service company headquartered in Berlin, Germany.

Pharmcontract Group becomes the 2017 industry leader

Pharmcontract Group was highly praised and recognized for its significant contribution to the development of the Russian economy, including both the fair payment of taxes and achievement of strong economic performance

WEF Davos 2018: Launching the ‘Antimicrobial Resistance Benchmark’

wef davos 2018
The first-ever Antimicrobial Resistance Benchmark will map the actions of 30 pharmaceutical companies across three research areas: Research & Development, Manufacturing and Production, Access & Stewardship

The output of pharmaceutical products in Russia grew by 12% over the year

Russian President Vladimir Putin held a working meeting with the Minister of Industry and Trade Denis Manturov. The Minister briefed Mr. Putin on the development of the real sector of the economy in 2017.

API market will reach a value of $239.8 billion by 2025

According to the report, recently published by Million Insights, the global Active Pharmaceutical Ingredient market size was worth at $134.2 billion in the year 2015

Russia has one of the shortest periods for expert examination of medicines

pharma manufacturing
Elena Maksimkina, the Director of the Department of Drug Supply and Regulation of Medical Devices, gave her assessment of the pharmaceutical market in Russia.